Analyst
Equibles does not estimate personal net worth.
Dean Li has spoken on 1 earnings call and 4 other investor events across 1 company, most recently for Merck & Co., Inc. on September 14, 2026. The companies whose calls Dean Li spoke on are classified in the Healthcare sector.
“So the first thing is, I think one of the most important pieces of data actually didn't come out in August. It came out during ASCO, where we together presented the five years from the phase two.”
“Yeah, I mean, essentially our initial strategy was not to protect lung and breast and to go everywhere else because we were a little bit surprised that other people hadn't done that.”
“Yeah, I mean, essentially our initial strategy was not to protect lung and breast and to go everywhere else because we were a little bit surprised that other people hadn't done that.”
“The second quarter was marked by several important regulatory and clinical milestones. Today, I will provide updates in cardiometabolic disease, HIV, infectious disease, immunology, and oncology.”
“It is my pleasure to share more about our pipeline today. We have reached an important juncture with multiple opportunities that have the potential to change the practice of medicine and positively impact the lives of patients.”
Drug Manufacturers - General · Healthcare
